Life Sciences Leaders Pivot Toward Foundational Integrity for Agentic AI

Axtria founder Jaswinder "Jassi" Chadha set the tone for the two-day summit by challenging the prevailing rush toward automation. With industry trust in AI systems dipping to 53%—down from 61% in 2019—Chadha argued that the sector must prioritize infrastructure before scaling. He outlined a mandate for success that includes establishing an AI-ready data supply chain, a semantic layer for agent accuracy, and strict software guardrails to meet the pharma industry’s 99.5% accuracy standard.

The Shift to Industrialized Intelligence

Beyond technical architecture, the sessions emphasized that the transition to an agentic enterprise is as much about human culture as it is about algorithms. During panel discussions, leaders from firms like Thermo Fisher Scientific and Quest Diagnostics highlighted that change management cannot remain an afterthought in business cases. A common theme emerged: successful adoption requires positioning AI as a tool to elevate human roles rather than replace them.

Recognition for these efforts was formalized through the Ignite Leadership Awards, which honored transformation leaders from Bristol Myers Squibb, GSK, and Biogen. Additionally, Axtria presented the Bedrock Honor to Quest Diagnostics, marking a 15-year partnership that recently culminated in the deployment of the Axtria SalesIQ™ platform across a 1,300-person field organization. As companies integrate these digital workers, the consensus remains that agents must earn their status through validation and audit, effectively acting as new hires rather than instant, perfect solutions.